Mobile

A Phase IIa, two-center, randomized, double-blind study with parallel groups to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus corresponding...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-016626-14

A Phase IIa, two-center, randomized, double-blind study with parallel groups to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus corresponding mono-substances in patients with inflammatory tinea pedis

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the efficacy of a combined octenidine/prednicarbate cream in comparison to creams with prednicarbate or octenidine alone after once daily treatment over a 2-week period in patients with inflammatory tinea pedis

Critère d'inclusion

  • 120 male or female patients with symptomatic moderate to severe tinea pedis will be randomized

Liens